AI summary · may contain errors
CPS + EG and Neo-Bioscore scores are linked to long-term outcomes at the patient level, but they do not predict long-term outcomes at the trial level in neoadjuvant therapy studies.
Cell Press · Oncology · ISSN 1535-6108, 1878-3686
Rebuilt
AI summary · may contain errors
CPS + EG and Neo-Bioscore scores are linked to long-term outcomes at the patient level, but they do not predict long-term outcomes at the trial level in neoadjuvant therapy studies.
AI summary · may contain errors
In 33 patients with Fusobacterium nucleatum–positive, microsatellite-stable metastatic colorectal cancer, tislelizumab plus fruquintinib and metronidazole achieved a median progression-free survival of 6.0 months.
AI summary · may contain errors
Pulsed, anaerobe-directed metronidazole combined with anti-PD-1 and a VEGF receptor inhibitor improved progression-free survival in Fusobacterium nucleatum-positive microsatellite-stable metastatic colorectal cancer.
Newest first · last 60 days
AI summary · may contain errors
In 33 patients with Fusobacterium nucleatum–positive, microsatellite-stable metastatic colorectal cancer, tislelizumab plus fruquintinib and metronidazole achieved a median progression-free survival of 6.0 months.
AI summary · may contain errors
Pulsed, anaerobe-directed metronidazole combined with anti-PD-1 and a VEGF receptor inhibitor improved progression-free survival in Fusobacterium nucleatum-positive microsatellite-stable metastatic colorectal cancer.
AI summary · may contain errors
DLL3-high small cell lung cancers linked to serotonin-driven immunosuppressive tumor-associated macrophages show resistance to the DLL3×CD3 T cell engager tarlatamab.
AI summary · may contain errors
A premalignant chromatin state linked to gastric cancer involves a pseudo-gastric subtype that exploits acid secretion to evade immune responses.
AI summary · may contain errors
In triple-negative breast cancer, neutrophil–tumor cell proximity is linked to favorable prognosis, and neutrophil–immune cell proximity predicts superior immunotherapy response.
AI summary · may contain errors
In fibrotic, immune-excluded tumors, FN-EDB-targeted sTGF-βRII (FEBP-sTβRII) suppresses TGF-β/SMAD signaling and reprograms CAF–myeloid niches to enable durable, T cell–dependent tumor regression and long-term cross-protection.
AI summary · may contain errors
Interferon signaling activation, especially IFN-β, determines sensitivity to KRAS G12D–targeted therapy in intrinsically resistant pancreatic cancer organoids, enabling synergistic drug combinations.
AI summary · may contain errors
In glioblastoma patients and female murine models, platelet PAR4 signaling is linked to increased platelet reactivity and suppresses CD8+ T cell–mediated anti-tumor immunity.
AI summary · may contain errors
Patel et al. integrate multi-omics across neuroblastoma patient-derived xenografts and annotated tumors to reveal distinct in vivo tumor cell populations linked to adrenergic and mesenchymal programs.
AI summary · may contain errors
Multi-omics profiling of microsatellite-stable colorectal cancer, integrated with patient-derived models, identifies focal adhesion kinase and phosphoinositide-dependent kinase 1 as promising therapeutic targets.
AI summary · may contain errors
The Neoantigen Quality Model proposes that T cell selection is maximized near self, yielding genomic-error antigens closer to self that overlap with pathogen antigens and are immunogenic non-self.
AI summary · may contain errors
A pseudo-gastric epigenomic subtype in gastric cancer is intrinsically drug resistant and characterized by an acid-driven immunotherapy resistance linked to FOSL2 activity.
AI summary · may contain errors
Sustained MYC activity suppresses innate immune signaling and is identified as the principal driver of intrinsic resistance to KRAS inhibition in patient-derived pancreatic ductal adenocarcinoma organoids.
AI summary · may contain errors
Multiomic profiling of microsatellite-stable (MSS) colorectal cancer across ~2,000 tumors identifies targetable vulnerabilities, including MEK-combination sensitivities in RAS-mutant MSS CRC models.
AI summary · may contain errors
Firmonertinib shows promising systemic and intracranial efficacy in EGFR PACC-mutant non-small cell lung cancer (NSCLC), supporting further clinical development for this mutation class.
AI summary · may contain errors
Firmonertinib produced confirmed objective response rates of 43% with 160 mg and 68% with 240 mg in first-line metastatic EGFR PACC-mutant NSCLC.
AI summary · may contain errors
Antibiotic exposure in 97,850 cancer patients treated with immune checkpoint inhibitors is significantly associated with worse overall survival (HR 1.49, 95% CI 1.34–1.65).
AI summary · may contain errors
Spatial omics and multi-omics profiling of 54 neuroblastoma tumors identify mesenchymal (MES) tumor cell states linked to worse event-free and overall survival.
AI summary · may contain errors
Two distinct neutrophil niches in triple-negative breast tumors are linked to different clinical outcomes, with tumor-proximal neutrophils tied to favorable prognosis.
AI summary · may contain errors
CPS + EG and Neo-Bioscore scores are linked to long-term outcomes at the patient level, but they do not predict long-term outcomes at the trial level in neoadjuvant therapy studies.
AI summary · may contain errors
In 8,359 early breast cancer patients from nine neoadjuvant randomized trials, CPS + EG and Neo-Bioscore predict individual residual risk, but trial-level surrogacy for long-term benefit is weak (R2 0.03–0.24).
AI summary · may contain errors
In mouse models and human GBM samples, tumor cells activate CSF1R–PI3K signaling in tumor-associated microglia/macrophages, driving secretion of LPCs and LPAs that promotes invasion.
AI summary · may contain errors
Hyeon et al. identify and map significantly mutated regions onto protein domains and structural features, enabling a proteo-genomics framework for interpreting cancer somatic mutations beyond genes and hotspots.
AI summary · may contain errors
In advanced lung cancer patients receiving radio-immunotherapy, radiation-induced TET2 expression in myeloid-derived suppressor cells correlates with poor outcomes.
AI summary · may contain errors
In 48 pretreated patients with metastatic KRAS G12D-mutant pancreatic ductal adenocarcinoma, HRS-4642 plus adebrelimab showed a 43.2% confirmed objective response rate at RP2D.
AI summary · may contain errors
An ensemble that combines five pretrained pathology foundation models into a slide-level representation improves tumor subtyping, biomarker, and therapy-response prediction in computational pathology.
AI summary · may contain errors
UniCure predicts patient-level, drug-induced transcriptomic responses by fine-tuning on 345 patient-derived tumor-like cluster profiles and validating on 396 clinical profiles.
AI summary · may contain errors
EMT-like CD44 high bladder cancer cells form spatial niches with SPP1/PARP14 high macrophages that drive chemoresistance to cisplatin.
Journals this month
Topics moving, week to 18 Nov 2026
By field